Squarepoint Ops LLC

Position in DSGN — Design Therapeutics, Inc.

CIK 1642575 NEW YORK, NY

Position in DSGN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$428,746

-$487,538 QoQ

Shares Held

29,630

-65.6% QoQ

Ownership

0.047%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#69

of 136 holders

Holding Since

Mar 2021

12 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

Squarepoint Ops LLC holds $1,238,596,915 across 255 Biotechnology names. DSGN ranks #157 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	198,567	$123,814,467
2	BBIO	BridgeBio Pharma, Inc.	1,191,732	$88,760,199
3	ALNY	Alnylam Pharmaceuticals, Inc.	233,999	$70,440,718
4	INSM	INSMED Inc	616,464	$65,727,391
5	ARGX	Argenx SE	58,400	$54,181,768
6	RYTM	Rhythm Pharmaceuticals, Inc.	422,921	$46,956,918
7	APGE	Apogee Therapeutics, Inc.	290,713	$38,586,336
8	AXSM	Axsome Therapeutics, Inc.	154,605	$37,842,665

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$428,746	29,630	-65.6%	Shares	Defined	2026-08-14
2026-03-31	$916,284	86,117	+86.6%	Shares	Defined	2026-05-15
2025-12-31	$432,811	46,142	-4.2%	Shares	Defined	2026-02-13
2024-12-31	$297,307	48,186	-43.4%	Shares	Defined	2025-02-14
2024-09-30	$458,004	85,131	-5.4%	Shares	Defined	2024-11-14
2024-06-30	$301,349	89,955	+146.9%	Shares	Defined	2024-08-14
2024-03-31	$146,841	36,437	-5.2%	Shares	Defined	2024-05-15
2023-12-31	$101,836	38,429	-9.7%	Shares	Defined	2024-02-14
2023-09-30	$100,446	42,562	+2.3%	Shares	Defined	2023-11-14
2023-06-30	$262,017	41,590	-61.9%	Shares	Defined	2023-08-14
2023-03-31	$630,164	109,214	+364.9%	Shares	Defined	2023-05-15
2021-03-31	$702,440	23,493	—	Shares	Defined	2021-05-17
No filing history on record for this holder in this stock.